University of Otago study finds less painful rheumatic heart disease treatment via stomach needle for larger penicillin doses every 3 months.

University of Otago study reveals a less painful method for treating rheumatic heart disease, caused by group A streptococcus infections. A small needle inserted into the stomach for a larger penicillin dose every three months is preferred by over 95% of trial participants, compared to monthly intramuscular injections. The Phase II clinical trial awaits Medsafe approvals and treatment guidelines before adoption.